We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Senate Bill Aims To Restrict Authorized Generics

Law360 (February 17, 2011, 2:24 PM EST) -- U.S. Senate Democrats are reviving a proposal to restrict brand-name pharmaceutical companies' ability to market authorized generics during the 180-day exclusivity window following the first successful challenge to a brand patent by a generic-drug maker.

S. 373, the Fair Prescription Drug Competition Act, was introduced in the Senate on Wednesday by Sens. Jay Rockefeller, D-W.Va.; Jeanne Shaheen, D-N.H.; Patrick Leahy, D-Vt.; Daniel Inouye, D-Hawaii; Debbie Stabenow, D-Mich.; and Charles Schumer, D-N.Y.

The legislation, which mirrors a similar bill introduced in several past sessions of Congress, aims...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.